Texas Cancer Center ( Medical City Dallas Hospital) Dept. of Texas Cancer Ctr. (2) is a clinical research site located in Dallas, Texas, United States 75230.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Texas Cancer Center ( Medical City Dallas Hospital) Dept. of Texas Cancer Ctr. (2) has participated in 1 clinical trials.
Therapeutic areas: HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Texas Cancer Center ( Medical City Dallas Hospital) Dept. of Texas Cancer Ctr. (2) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Cancer Center ( Medical City Dallas Hospital) Dept. of Texas Cancer Ctr. (2) has 1 clinical trials on record. Their work covers HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.
Texas Cancer Center ( Medical City Dallas Hospital) Dept. of Texas Cancer Ctr. (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.